FTSE MIB
33.629,21 -107,19 (-0,32%) Dow Jones
38.675,68 +450,02 (+1,18%) Nasdaq
16.156,33 +315,37 (+1,99%) Nikkei 225
38.236,07 -37,98 (-0,10%) Petrolio
77,99 -0,96 (-1,22%) Bitcoin EUR
59.339,26 +747,70 (+1,28%)
Kiniksa Pharmaceuticals, Ltd. (KNSA)
Dopo ore:
| Chiusura precedente | 19,38 |
| Aperto | 20,13 |
| Denaro | 20,03 x 100 |
| Lettera | 20,12 x 200 |
| Min-Max giorno | 19,63 - 20,40 |
| Intervallo di 52 settimane | 12,94 - 22,09 |
| Volume | |
| Media Volume | 387.666 |
| Capitalizzazione | 1,424B |
| Beta (5 anni mensile) | 0,30 |
| Rapporto PE (ttm) | 154,46 |
| EPS (ttm) | 0,13 |
| Prossima data utili | 23 lug 2024 - 29 lug 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 30,00 |
GlobeNewswireKiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio Execution
– ARCALYST® (rilonacept) Q2 2023 net product revenue of $54.5 million –– ARCALYST 2023 net product revenue guidance increased to $220 - $230 million, representing ~84% year-over-year growth at the midpoint –– KPL-404 Phase 2 rheumatoid arthritis data expected in 1H 2024 –– Cash reserves now expected to fund operations into at least 2027 –– Conference call and webcast scheduled for 8:30 am ET today – HAMILTON, Bermuda, July 25, 2023 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA)
- GlobeNewswire
Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023
HAMILTON, Bermuda, July 18, 2023 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, July 25, 2023 at 8:30 a.m. Eastern Time to report its second quarter 2023 financial results and recent portfolio execution. A live webcast will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. Individuals interested in participating in the call via telephone may register h
- GlobeNewswire
Kiniksa Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference
HAMILTON, Bermuda, June 06, 2023 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that management will participate in a fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13, 2023 at 8:40 a.m. Pacific Time (11:40 a.m. Eastern Time). A live webcast of Kiniksa’s presentation will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Ki
